OpenQ Posts a 200% Revenue Growth in the First Half of 2009
OpenQ announces solid revenue
growth for the first half of 2009 and is now serving 7 of the Top 10 pharmaceutical and 3 of the Top 5 medical device companies.
Charlottesville, VA, San Diego, CA, New York, NY and Paris, France (PRWEB) July 18, 2009 -- OpenQ, a leading pr...
PDL BioPharma Provides Second Quarter 2009 Revenue Guidance of Approximately $125 Million
INCLINE VILLAGE, Nev., June 8 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today announced revenue
guidance for the second quarter ended June 30, 2009 of approximately $125 million, as compared with $106 million for the second quarter of 2008. The increase is due pr...
Providence Health & Services Increases Revenue by $35 Million Using Concuity ClearContracts
Providence expands use of Concuity products across 16 facilities following success to date increasing net revenue
VERNON HILLS, Ill., June 8 /PRNewswire-FirstCall/ -- Concuity, A Healthcare Division of Trintech, Inc. (Nasdaq: TTPA ) announced today that Providence Health & Service...
Neptune Technologies Reports Fiscal 2009 Results - Record revenue and profitability growth in nutraceutical business
LAVAL, QC, May 19 /PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) today reports its consolidated financial results for the fiscal year ended February 28, 2009. Neptune reports record revenues, EBITDA(1) and first-time profitability for t...
Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets
PRINCETON, N.J., April 29 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD ) today reported earnings for its first quarter ended March 31, 2009 of $0.63 per diluted share versus $0.76 per diluted share in the first quarter of 2008 (or $0.73 per diluted share after excluding the centralized ECG ...
Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008
New Molecular Tests and Increasing Case Volumes Drive 78 Percent Revenue
Growth in the Fourth Quarter of 2008 as Compared to the Prior Year Period
ALISO VIEJO, Calif., March 11 /PRNewswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT ), a premier anatomic pathology and molecular testing ser...
VirtualScopics Achieves Operating Cash Flow Breakeven in the Fourth Quarter 2008; Reports Record 2008 Revenue and Gross Profit
4th quarter gross profit grows by nearly 90%, operating loss reduced by 73%
ROCHESTER, N.Y., Feb. 25 /PRNewswire-FirstCall/ -- VirtualScopics, Inc. (Nasdaq: VSCP ), a leading provider of quantitative imaging for clinical trials, announced today that revenues for the fourth quarter of 2008 w...
iCardiac Reports Significant Revenue Growth and Profitability
iCardiac Continues to Successfully Leverage Differentiated Service and Product Offering
Rochester, New York (PRWEB) February 23, 2009 -- iCardiac Technologies, Inc., a leading innovator in advanced cardiac safety biomakers and automated QT analysis, today announced that...
On Third Anniversary, Compendia Bioscience Announces Continued Revenue Growth, Major Long-Term Customer Contracts and Forecasts Profitability
ANN ARBOR, Mich., Feb. 10 /PRNewswire/ -- Compendia Bioscience, Inc. today announced the results of a third productive year, including a 100 percent renewal rate from its customers. New customers and increased commitments from existing customers, including multi-year agreements from three of the T...
Caliper Life Sciences Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
HOPKINTON, Mass., Jan. 15 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP ) today announced preliminary revenue
results for its 2008 fourth quarter and full year ended December 31, 2008.
Based on the company's preliminary financial results, total revenue
is expected to b...
Cepheid Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
SUNNYVALE, Calif., Jan. 13 /PRNewswire-FirstCall/ -- Cepheid
(Nasdaq: CPHD ) today announced preliminary revenue
results for its 2008 fourth
quarter and full year ended December 31, 2008.
Based on the company's preliminary financial results, total revenue
the fourth quarter of 200...
Simcere Pharmaceutical Group Announces Preliminary Full Year Revenue and Earnings
NANJING, China, Jan. 12 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group
(NYSE: SCR ), a leading manufacturer and supplier of branded generic
pharmaceuticals and manufacturer of the patented anti-cancer biotech product
Endu (also known as Endostar) in China, today announced preliminary reve...
Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance
CARY, N.C., Dec. 11 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq: CRTX ), a specialty pharmaceutical company focused on developing and commercializing prescription medications for respiratory disorders, today provided an update on the status of its integration activities follo...
Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth
CHENGDU, China, Dec. 2 /PRNewswire-Asia-FirstCall/ -- Tianyin
Pharmaceutical, Co., Inc., (NYSE EuroNext: TPI), a manufacturer and supplier
of modernized traditional Chinese medicine ("TCM") based in Chengdu, China,
today announced the implementation of a new sales and marketing strategy to
Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year
- Fourth quarter constant currency revenue
growth of 12.9 percent
- Full year revenue
growth of 11.1 percent (9.0 percent, constant currency)
and improving profitability reflects success of strategic initiatives
- Management reaffirms annual financial guidance for fiscal year 2009
InfuSystem Holdings Reports 14.5% Revenue Increase and Approximately $3.6 Million of Adjusted EBITDA for the Third Quarter of 2008
MADISON HEIGHTS, Mich., Nov. 5 /PRNewswire-FirstCall/ --InfuSystem
Holdings, Inc. (OTC Bulletin Board: INHI; INHIW; INHIU), the leading
provider of ambulatory infusion pumps and associated clinical services,
today announced financial results and provided a business update for the
Cepheid Reports Third Quarter Revenue of $44.9 Million
GeneXpert(R) System Momentum Drives 71% Year-Over-Year Growth in Core Clinical Business
SUNNYVALE, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq:
CPHD) today reported revenue
for the third quarter of 2008 of $44.9
million, an increase of 24% over the thir...
PAREXEL Consulting Quantifies Speed to Market: First-Cycle Approval for NME Produces $640 Million in Incremental Revenue on Average
BOSTON, Oct. 16 /PRNewswire-FirstCall/ -- Gaining a first-cycle
approval for a new molecular entity (NME) is worth an estimated $640
million in incremental revenue
on average, according to a new analysis from
PAREXEL Consulting, a business unit of PAREXEL International (Nasdaq: PRXL )
CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase
Achieves Positive Operating Income Excluding Non-Cash Charges
SAN DIEGO, Oct. 9 /PRNewswire-FirstCall/ -- CardioDynamics (Nasdaq:
CDIC), the innovator and leader of BioZ(R) Impedance Cardiography (ICG)
technology, today reported financial results for fiscal third quarter 2008.
China Sky One Medical, Inc. Raises Guidance for 2008 Revenue and Net Income
-- Expects Revenue
of $88 to $90 Million and Net Income of $27 to $28 Million
HARBIN, China, Sept. 25 /Xinhua-PRNewswire-FirstCall/ -- China Sky One
Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI ), a
leading fully integrated pharmaceuti...
Animetrics Inc. Named One of Business NH Magazine's '10 Companies to Watch' for its Significant Revenue Growth
Business Journal to Honor http://www.animetrics.com/ [Animetrics] at "Top 100 Private Companies" Event in October
Conway, NH (PRWEB) September 24, 2008 -- Animetrics® Inc., a leading developer of 3D imaging for facial biometric systems, today announced t...
China Pharma Holdings, Inc. Projects 3rd Quarter 2008 Revenue Growth to Exceed 40% Revenue
Guidance with Q3 2008 Forecasts Growth of More Than 40%
NEW YORK and HAIKOU CITY, Hainan, China, Sept. 18 /Xinhua-PRNewswire-
FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin
Board: CPHI) which develops, manufactures, and markets generic and brand
AMDL Inc. Announces Second Quarter 2008 Results; Company Posts $5.8 Million in Sales With a Revenue Increase of 140%
TUSTIN, Calif., Aug. 15 /PRNewswire-FirstCall/ -- ( http://www.amdl.com )
AMDL Inc. (Amex: ADL ), a leading vertically integrated bio-pharmaceutical
company with major operations in China and the US, today reported today
unaudited results and the filing of its Quarterly Report on Form 10-Q wi...
Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.
BASINGSTOKE, England and PHILADELPHIA, July 31 /PRNewswire-FirstCall/
-- Shire Limited (LSE: SHP, NASDAQ: SHPGY) the global specialty
biopharmaceutical company announces results for the three months to June
Q2 2008 Financial Highlights
- Product sales up 40% to $706m - Produ...
Startup Nanotech Firm Books First Revenue From Large Chip Makers
Carbon Nanoprobes, Inc. receives custom orders from leading semiconductor manufacturers, officially putting revenue
on the company's books.
Seattle, WA (PRWEB) July 30, 2008 -- Carbon Nanoprobes, Inc ( www.cnprobes.com [CN Probes™]), an emerging nanotech solution...
Cepheid Reports Second Quarter Revenue of $42.1 Million
65 Percent Increase in Product Sales Driven by Robust MRSA Growth
SUNNYVALE, Calif., July 24 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq:
CPHD) today reported revenue
for the second quarter of 2008 of $42.1
million, an increase of 55% over the second quarter of fiscal 2007. Net
loss was $7.5 ...
Cyberonics Reports Strong Revenue Growth and Profitability in Fiscal 2008 Fourth Quarter
Epilepsy Growth of 14% Fiscal 2009 Revenue
HOUSTON, June 11 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq:
CYBX) today announced results for the fourth quarter, and fiscal year,
ended April 25, 2008.
Key quarterly highlights
Immucor Announces Fiscal Year 2009 Revenue and Earnings Guidance
NORCROSS, Ga., June 4 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq:
BLUD), a global leader in providing automated instrument-reagent systems to
the blood transfusion industry, today announced revenue
guidance for the fiscal year ending May 31, 2009.
For fiscal year 2009:
BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even
BioElectronics President, CEO, and Chairman recaps recent investor conference call
FREDERICK, Md., May 22 /PRNewswire-FirstCall/ -- Andrew Whelan,
President and CEO of BioElectronics Corporation (Pink Sheets: BIEL), the
developer of ActiPatch, an FDA-cleared, drug...
ATS Medical Announces Record Quarterly Revenue and Gross Profit
First Quarter 2008 Revenue
Increases 37.5% to $14.8 Million Gross Profit Margin at 60.3% Sets Quarterly Record Company Raises Revenue
MINNEAPOLIS, May 5 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq:
ATSI), manufacturer and marketer of state-of...
Osteotech Posts First Quarter Earnings Per Share of $.05 on Revenue Growth of 10%
EATONTOWN, N.J., May 1 /PRNewswire-FirstCall/ -- Osteotech, Inc.
(Nasdaq: OSTE ), a leader in the emerging field of biological products for
regenerative healing, announced today that revenue
for the first quarter of
2008 increased 10% to $27.6 million from $25.2 million for the first
LeMaitre Vascular Reports Q1 2008 Revenue of $11.8 Million, a 20% Increase
BURLINGTON, Mass., April 30 /PRNewswire-FirstCall/ -- LeMaitre
Vascular, Inc. (Nasdaq: LMAT ), a provider of peripheral vascular devices
and implants, today announced financial results for Q1 2008. Q1 2008
revenues were $11.8 million, an increase of 20% over Q1 2007.
Q1 2008 revenues increa...
Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth
- Gross Margin Increases 430 Basis Points from the First Quarter of 2007 to 66.3% - Company Prepares to Launch Newest Generation of Laser Lipolysis Technology
WESTFORD, Mass., April 29 /PRNewswire-FirstCall/ -- Cynosure, Inc.
HealthEast Care System Selects Concuity's ClearContracts to Increase Contract Analysis and Negotiation Capabilities and Improve Revenue Cycle Management
VERNON HILLS, Ill. and DUBLIN, Ireland, April 21 /PRNewswire-FirstCall/
-- Concuity, a healthcare division of Trintech (Nasdaq: TTPA ) and a leading
provider of contract management and revenue
recovery technology ("Peer
Reviewed by HFMA") and services, today announced that HealthEast Care
ATS Medical Expects First Quarter Revenue of $14.6 to $14.8 Million Revenue
from non-mechanical heart valve businesses expected to grow by over 100%, year-over-year
MINNEAPOLIS, April 3, 2008 /PRNewswire-FirstCall/ -- ATS Medical, Inc.
(Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac
surgery products and services, ...
As Billions in Blockbuster Drug Revenue Goes Off Patent, Life Sciences Companies are Challenged to Fundamentally Change Future R&D Strategies, According to New Deloitte Report
NEW YORK, April 2, 2008 /PRNewswire-USNewswire/ -- Pharmaceutical
companies currently challenged with replacing the $65 billion worth of
product expected to go off patent in the next four years must dramatically
rethink their R&D models for future success, according to a new report
Plethora and Paul Capital Healthcare sign a $25 million revenue interest financing agreement with an option for an additional $3 million equity investment
LONDON, April 1, 2008 /PRNewswire/ -- Plethora Solutions Holdings PLC
("Plethora", AIM: PLE), the developer of specialist products for the
treatment and management of urological disorders, today announced that it
has entered into a revenue
interest financing agreement with Paul Capital
Profarma's Gross Revenue Reached R$ 740,4 Million in the 4th Quarter of 2007, a 40,1% Growth Over the Same Period in the Last Year
RIO DE JANEIRO, Brazil, Feb. 26 /PRNewswire-FirstCall/ -- One of
Brazil's leading distributors of pharmaceutical products, Profarma
Distribuidora de Produtos Farmaceuticos S.A. ("Profarma" or the "Company")
(Bovespa: PFRM3) has just announced its results for the fourth quarter of
2007 (4Q07) a...
Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%
BASINGSTOKE, England and PHILADELPHIA, February 21
/PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global
specialty biopharmaceutical company announces results for the twelve months
to December 31, 2007 - a year which has seen significant growth in launched
Phlo Reports Sharp Revenue Increase
JACKSONVILLE, Fla., Feb. 21 /PRNewswire-FirstCall/ -- Phlo Corporation
(Pink Sheets: PHLC) (the "Company") reported revenue
during the three and
nine-month periods ended December 31, 2007 of $190,072 and $320,256,
respectively, as compared with revenue
during the three and nine-month